Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women

被引:98
作者
Bélec, L
Ghys, PD
Hocini, H
Nkengasong, JN
Tranchot-Diallo, J
Diallo, MO
Ettiègne-Traore, V
Maurice, C
Becquart, P
Matta, M
Si-Mohamed, A
Chomont, N
Coulibaly, IM
Wiktor, SZ
Kazatchkine, MD
机构
[1] Hop Europeen Georges Pompidou, Virol Lab, F-75908 Paris 15, France
[2] Hop Broussais, INSERM, U430, F-75674 Paris, France
[3] Univ Paris 06, Paris, France
[4] Projet RETRO CI, Abidjan, Cote Ivoire
[5] Programme Natl Lutte SIDA Malad Sexuellement Tran, Abidjan, Cote Ivoire
[6] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
D O I
10.1086/324375
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antibodies to human immunodeficiency virus (HIV) of the IgA, IgG, and IgM isotypes and high levels of the HIV suppressive beta -chemokine RANTES (regulated on activation, normally T cell expressed and secreted) were found in the cervicovaginal secretions (CVSs) of 7.5% of 342 multiply and repeatedly exposed African HIV-seronegative female sex workers. The antibodies are part of a local compartmentalized secretory immune response to HIV, since they are present in vaginal fluids that are free of contaminating semen. Cervicovaginal antibodies showed a reproducible pattern of reactivity restricted to gp160 and p24. Locally produced anti-env antibodies exhibit reactivity toward the neutralizing ELDKWA epitope of gp41. Study results show that antibodies purified from CVSs block the transcytosis of cell-associated HIV through a tight epithelial monolayer in vitro. These findings suggest that genital resistance to HIV may involve HIV-specific cervicovaginal antibody responses in a minority of highly exposed HIV-seronegative women in association with other protecting factors, such as local production of HIV-suppressive chemokines.
引用
收藏
页码:1412 / 1422
页数:11
相关论文
共 55 条
[1]   Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1 [J].
Alfsen, A ;
Iniguez, P ;
Bouguyon, E ;
Bomsel, M .
JOURNAL OF IMMUNOLOGY, 2001, 166 (10) :6257-6265
[2]  
ANDERSON DJ, 1995, KEYST S MOL CELL BIO
[3]   ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS IN CERVICAL SECRETIONS FROM WOMEN AT RISK FOR AIDS [J].
ARCHIBALD, DW ;
WITT, DJ ;
CRAVEN, DE ;
VOGT, MW ;
HIRSCH, MS ;
ESSEX, M .
JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (01) :240-241
[4]  
Archibald DW, 1992, VACCINE RES, V1, P215
[5]   Compartmentalization of the IgG immune response to HIV-1 in breast milk [J].
Becquart, P ;
Hocini, H ;
Garin, B ;
Sépou, A ;
Kazatchkine, MD ;
Bélec, L .
AIDS, 1999, 13 (11) :1323-1331
[6]   HIV-1 ANTIBODY SERUM NEGATIVITY WITH VAGINAL SECRETIONS POSITIVITY [J].
BELEC, L ;
TEVIBENISSAN, C ;
GRESENGUET, G ;
MEILLET, D ;
PILLOT, J .
LANCET, 1994, 343 (8904) :1046-1047
[7]   DETECTION OF SEMINAL ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS IN VAGINAL SECRETIONS AFTER SEXUAL INTERCOURSE - POSSIBLE MEANS OF PREVENTING THE RISK OF HUMAN-IMMUNODEFICIENCY-VIRUS TRANSMISSION IN A RAPE VICTIM [J].
BELEC, L ;
MATTA, M ;
PAYAN, C ;
TEVIBENISSAN, C ;
MEILLET, D ;
PILLOT, J .
JOURNAL OF MEDICAL VIROLOGY, 1995, 45 (01) :113-116
[8]   ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS IN THE SEMEN OF HETEROSEXUAL MEN [J].
BELEC, L ;
GEORGES, AJ ;
STEENMAN, G ;
MARTIN, PMV .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) :324-327
[9]   Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection [J].
Belec, L ;
TeviBenissan, C ;
Dupre, T ;
Mohamed, AS ;
Prazuck, T ;
Gilquin, J ;
Kanga, JM ;
Pillot, J .
JOURNAL OF CLINICAL IMMUNOLOGY, 1996, 16 (01) :12-20
[10]   ANTIBODIES TO HUMAN IMMUNODEFICIENCY VIRUS IN VAGINAL SECRETIONS OF HETEROSEXUAL WOMEN [J].
BELEC, L ;
GEORGES, AJ ;
STEENMAN, G ;
MARTIN, PMV .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (03) :385-391